ALS mortality forecast
Amyotrophic lateral sclerosis (ALS) patients can gain a clearer view of their prognosis. Researchers built machine learning models that predict 6- and 12-month death risk from any clinic visit using routine blood work and measures, not needing imaging or genetic tests. They work with as few as seven features and stay accurate across North American and Singaporean data, guiding care plans and trial choices.
Research#Motor Neurone Disease (MND)#Amyotrophic Lateral Sclerosis (ALS)#Machine Learning